A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
Status:
Completed
Trial end date:
2018-06-14
Target enrollment:
Participant gender:
Summary
This study is designed to assess whether consumers select and use ella® (ulipristal acetate
30mg), an emergency contraceptive, in a manner consistent with the OTC package directions in
an OTC-like setting.